Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2011; 17(13): 1694-1700
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1694
Published online Apr 7, 2011. doi: 10.3748/wjg.v17.i13.1694
Figure 4 Effects of legalon-SIL on heme oxygenase-1, Bach1, and nuclear factor erythroid 2-related factor 2 mRNA levels after 24 h.
CON1 cells were grown to near confluence and medium was changed to 5% FBS plus Dulbecco’s modified Eagle’s medium, then treated with vehicle only (DMSO) or 50 or 200 μmol/L legalon-SIL (LS). The cells were harvested 24 h after treatment. The levels of HMOX-1, Bach1, and nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA were quantified using quantitative reverse transcriptase polymerase chain reaction as described in “Materials and Methods”. The amounts of HMOX-1, Bach1, and Nrf2 mRNA were normalized to glyceraldehyde-3-phosphate dehydrogenase. Data are presented as the mean ± SE experiments were performed 3 times. bP < 0.01 vs DMSO control.
- Citation: Mehrab-Mohseni M, Sendi H, Steuerwald N, Ghosh S, Schrum LW, Bonkovsky HL. Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV. World J Gastroenterol 2011; 17(13): 1694-1700
- URL: https://www.wjgnet.com/1007-9327/full/v17/i13/1694.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i13.1694